Indivior Pharmaceuticals, Inc. INDV Business Segments — Gross Profit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's business segments — gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's business segments — gross profit?
- Indivior Pharmaceuticals, Inc. (INDV) reported business segments — gross profit of $277M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's business segments — gross profit changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's business segments — gross profit increased by 25.3% year-over-year, from $221M to $277M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's business segments — gross profit?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's business segments — gross profit has grown at a 9.9% compound annual growth rate (CAGR), from $749M to $993M.
- What does business segments — gross profit mean?
- Calculated as net revenue minus the cost of sales for the reportable segment. It reflects the core profitability of the segment's product portfolio before accounting for operating expenses.